Health Canada says neffy spray could be on the market as soon as this summer.Sean Kilpatrick/The Canadian Press
Health Canada has approved the first needle-free epinephrine treatment for severe allergic reactions: a nasal spray called neffy.
ALK Canada, which purchased the rights to distribute the drug, says the two-milligram treatment has been approved for adults and pediatric patients who weigh at least 30 kilograms – roughly 66 lbs.
It says the spray could be on the market as soon as this summer.
As it stands, epinephrine auto-injectors – known by the brand name EpiPen – are the only emergency treatment option available for allergic reactions.
EpiPens are single-use, pre-filled devices used to shoot a dose of epinephrine into the muscle.
Neffy was approved for use in the United States in summer 2024, where it is also available in a one-milligram dose for kids who weigh 15 to 30 kg. That dose has not been approved in Canada.
Food Allergy Canada is applauding the approval of the two-milligram treatment as “an important step forward” that gives Canadians more choices.






![15th Apr: Made with Love (2026), 8 Episodes [TV-14] (6/10) 15th Apr: Made with Love (2026), 8 Episodes [TV-14] (6/10)](https://occ-0-533-1007.1.nflxso.net/dnm/api/v6/0Qzqdxw-HG1AiOKLWWPsFOUDA2E/AAAABaImi05yxrzG23UJy7DfDv6tElqrUm21_W4J8mbHK-fP89B4ouaQ_rN509TcYNuBNZk2kxcm1r2L5UH7elc-GDfdok2hAdbiCpEpFLH4dn6neMNuP8Menhzd_1Rse6ediliHVL-Mz28l0xiVPNy31aaJW_dHIc_wXNWqKErid9QFkA.jpg?r=cf5)




